173 related articles for article (PubMed ID: 19091993)
1. Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles.
Gehring S; Gregory SH; Wintermeyer P; Aloman C; Wands JR
Clin Vaccine Immunol; 2009 Feb; 16(2):163-71. PubMed ID: 19091993
[TBL] [Abstract][Full Text] [Related]
2. Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.
Wintermeyer P; Gehring S; Eken A; Wands JR
J Viral Hepat; 2010 Oct; 17(10):705-13. PubMed ID: 20002303
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of an immunogenic dendritic cell population.
Gehring S; Gregory SH; Wintermeyer P; San Martin M; Aloman C; Wands JR
J Immunol Methods; 2008 Mar; 332(1-2):18-30. PubMed ID: 18258252
[TBL] [Abstract][Full Text] [Related]
4. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction.
Aloman C; Gehring S; Wintermeyer P; Kuzushita N; Wands JR
Gastroenterology; 2007 Feb; 132(2):698-708. PubMed ID: 17258730
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens.
Kuzushita N; Gregory SH; Monti NA; Carlson R; Gehring S; Wands JR
Gastroenterology; 2006 Feb; 130(2):453-64. PubMed ID: 16472599
[TBL] [Abstract][Full Text] [Related]
6. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
Encke J; zu Putlitz J; Geissler M; Wands JR
J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
[TBL] [Abstract][Full Text] [Related]
7. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
[TBL] [Abstract][Full Text] [Related]
8. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
J Viral Hepat; 2008 Jun; 15(6):459-70. PubMed ID: 18221298
[TBL] [Abstract][Full Text] [Related]
9. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
10. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection.
Encke J; Bernardin J; Geib J; Barbakadze G; Bujdoso R; Stremmel W
World J Gastroenterol; 2006 Nov; 12(44):7118-25. PubMed ID: 17131473
[TBL] [Abstract][Full Text] [Related]
11. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.
Yu H; Huang H; Xiang J; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2006 Jan; 87(Pt 1):1-10. PubMed ID: 16361412
[TBL] [Abstract][Full Text] [Related]
13. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
14. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
[TBL] [Abstract][Full Text] [Related]
15. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
16. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
[TBL] [Abstract][Full Text] [Related]
17. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
Wang QC; Feng ZH; Zhou YX; Nie QH
World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
[TBL] [Abstract][Full Text] [Related]
18. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
[TBL] [Abstract][Full Text] [Related]
19. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
[TBL] [Abstract][Full Text] [Related]
20. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
